*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Linezolid (Form I) is the stable crystalline polymorph of a synthetic oxazolidinone antibiotic. Its core process involves controlled crystallization to ensure high purity. The molecular formula is <strong>C<sub>18</sub>H<sub>20</sub>N<sub>4</sub>O<sub>5</sub></strong> with CAS No. <strong>170926-19-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Active pharmaceutical ingredient (API) for treating resistant Gram-positive infections.</li>
<li><strong>Antibiotic Formulation:</strong> Key component in oral tablets and intravenous solutions for MRSA and VRE.</li>
<li><strong>Quality Control:</strong> Reference standard for analytical testing in drug development pipelines.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly monitor for serotonin syndrome and myelosuppression during long-term therapy. Store in sealed containers at 2-8°C protected from light to maintain polymorphic stability.</p>